Introduction

The Global Fund (GF) is at an inflection point with the looming challenge of a funding crunch given that its last replenishment, co-hosted by the Republic of South Africa, fell way short of expectations (US$6.1 billion short) with pledges still pending even from historical donors. Therefore, the Global Fund's 54th Board meeting (11 - 13 February 2026) is critical amid global financial shifts and preparations for the next grant cycle in the backdrop of deep reductions in Official Development Aid and the emergence of the self-reliance agenda.

In this context, the Board document GF/B54/06 "Strategic Shifts for GC8: Supporting Progressive Sustainability and Effective Transitions" represents a turning point since the 2017 Sustainability, Transition and Co-financing Policy to reconcile its operational model with shifting geopolitical and fiscal realities in a world in constant mutation. We will examine this document's key propositions, identify the weaknesses, and suggest strategic recommendations.

What is this document about?

The GF Secretariat argues that transitions can be "intentional, predictable, planned, transparent, and appropriate to context" despite acknowledging that "many factors (are) outside Global Fund Partnership control." This framing represents a mature departure from previous eras, in which transition was discussed primarily as an endpoint rather than a process.

The proposed shift toward establishing defined timelines for some countries in GC8 and GC9, coupled with differentiated transition pathways across the entire portfolio, acknowledges what country-level observers have long noted: that the absence of predictable or tentative timelines has encouraged recipient countries to treat transition as a distant event rather than an imminent planning horizon.

The proposed cohort model, depicted in the document's visualization of potential transition timelines, introduces stratification that did not previously exist in formal policy communications. This carries both operational utility and political risk. Upper-middle-income countries and those with demonstrated fiscal capacity can now anticipate their allocation trajectories. However, the document does not indicate which countries belong to which cohort, a lack of transparency that could weaken the predictability the policy aims to create, even with the possibility of being guided by the Organization for Economic Cooperation and Development (OECD) categories.

The GF also seems to commit itself to a differentiated approach, a strategy long evoked but now better articulated and clearer. Worth mentioning is that, the current “strategy” implies an adaptation for the Challenging Operating Environments (COE) countries that felt trapped in the past.

Co-financing: from compliance exercise to strategic level

The document identifies co-financing as a key lever, but its implementation reveals unresolved tensions. However, the Secretariat reports that GC7 commitment letters from 89 countries represent a "20% increase on GC6 baselines." This quantitative achievement masks qualitative stagnation. The persistent challenge acknowledged in the finding that two-thirds of High Impact/Core countries carry "Very High or High co-financing risk" is that commitment letters do not equal disbursed expenditures, and disbursed expenditures do not equal additional domestic resources.

The analysis for GC6 compliance is particularly informative. Thirty-seven per cent of waivers were approved due to "limitations in domestic finance data and a need to reset expenditure baselines." This is soft language for a recurrent problem: after nearly two decades of co-financing requirements, the Global Fund still cannot reliably verify what governments were spending on HIV, tuberculosis and malaria at baseline, let alone what they add over time, knowing that some of the co-financing investments get merged in the national health accounts (like electricity bills, buildings, etc.).

The Secretariat's proposed shift toward "enhanced focus on commitments to finance specific programmatic interventions" represents a tacit admission that aggregate health expenditure targets have proven unenforceable and unverifiable. This programmatic earmarking approach, already visible in GC7 commitments such as Nigeria's US$360 million for Community Health Extension Workers or Malaysia's assumption of civil society HIV service financing, offers clearer accountability chains. The missed opportunity lies in the document's failure to propose systematic independent verification of these commitments. Self-reporting by Principal Recipients, filtered through Country Coordinating Mechanisms that include ministries of finance responsible for the commitments being monitored, creates inherent conflicts of interest that remain unaddressed.

On the other hand, Country B in the document's illustrative examples (see below), where "methodology applied to understand GC6 expenditures vs GC6 projections underlying co-financing requirements were not aligned and, therefore, not comparable”, is not an exception. It is the rule across dozens of portfolios.

Transition funding and the post-transition

The plan or treatment of the post-transition engagement is where strategic thinking is less developed. Twelve components across eight countries are transitioning during GC7, building on 52 completed transitions since the Global Fund's founding. Yet, the discussion of "post transition strategies" describes them as "critical to determine and define" and acknowledges that outcomes "will largely be influenced by country action, decision-making, and prioritization." without a clear road map.

This is insufficient. Costa Rica's voluntary transition, presented as a success story, was supported by a nine-month costed extension—a period that corresponds to approximately one reporting cycle for UNAIDS, rather than the multi-year horizon required to assess whether prevention services for key populations sustain coverage levels. Malaysia's commitment to fully finance its HIV response by 2028 is genuine progress, but the document does not address what monitoring role, if any, the Global Fund will maintain when domestic financing fully replaces grant resources. The Partnership's epidemiological surveillance systems were not designed to function as accountability mechanisms for sovereign budget execution.

Countries approaching transition face a binary choice: remain in the grant portfolio with continued access to technical assistance and quality-assured procurement or exit and become ineligible for both. Several middle-income countries have extended their transition timelines not because epidemiological conditions warrant it, but because the post-transition landscape offers no intermediate status. The document proposes that differentiation does not yet extend to creating formal associate or alumni categories with scaled engagement.

The African context: sovereignty, fiscal space and the Accra reset

Africa receives extensive attention throughout the document, appropriately given that the continent accounts for approximately 70 per cent of Global Fund allocations. The framing has shifted notably from previous cycles. "Health sovereignty" appears repeatedly, explicitly linked to the Accra Reset established during the 2024 Africa Health Sovereignty Summit.

The African regional examples of transition pathways reveal deeper tensions. The LIC Africa case involving a "health workforce investment compact" commits the Ministry of Finance to "progressive absorption of wage bill expansion." This is precisely the kind of concrete, multi-year fiscal commitment the policy seeks to incentivize. Yet, the document does not address what recourse exists if, three years into implementation, macroeconomic conditions deteriorate and wage bill absorption stalls. The Global Fund has no enforcement mechanism beyond grant suspension—a tool so blunt it damages the very programs both parties seek to protect.

The Nigeria health insurance case study illustrates both the potential and the limitations of current approaches. The Global Fund invested US$10 million to extend insurance coverage to people living with HIV and vulnerable populations in TB hotspots across five states. This intervention recognizes that sustaining disease-specific gains requires functional universal health coverage mechanisms. However, the document notes that this investment be "accompanied by an evaluation to generate evidence" for potential scale-up in the next grant cycle.

The Memorandum of Understanding with the African Union Commission, the Intergovernmental Authority on Development, and the West African Health Organisation signals recognition that health financing advocacy must operate at regional political levels, not solely through bilateral grant negotiations. This is a genuine strategic advance. Its effectiveness will depend on whether these relationships translate into sustained engagement between Global Fund governance bodies and African heads of state, rather than technocratic coordination among secretariats.

What does the document not address?

Three strategic gaps merit specific attention.

The role of civil society financing in transition contexts remains under-theorized.

The document discusses social contracting in Belize, Algeria, and the Colombia-World Bank-Global Fund joint investment. It highlights Malaysia's transition, where the government assumes financing for civil society organisations. However, many population-led services face sustainability risks because they require confidentiality and community-specific skills beyond those available in government health facilities. The document does not analyze how many supported community and civil society organisations have secured domestic funding commitments or are on track. This omission reflects the political difficulty of forcing governments to finance services for populations they prefer not to acknowledge.

The Secretariat does not confront the implications of its own blended finance ambitions for grant architecture.

The document states that the World Bank-Global Fund Memorandum of Understanding stipulates that "at least 10 countries to be identified for GC8 joint financing transactions," and that the African Development Bank has been pre-qualified as a blended finance partner. However, combining loans with grants fundamentally changes the risk profile of Global Fund investments. When a World Bank loan includes disbursement-linked indicators co-designed with the Global Fund, non-performance triggers have implications for sovereign debt, not just grant reallocation. Also, the document provides no framework for how the Partnership will manage this increase in financial consequences.

The treatment of data systems as a prerequisite for transition remains aspirational.

The GC6 waiver analysis notes that countries with limited public financial management systems can track only some health spending, such as HIV, TB, and malaria. This isn't a solvable technical issue that can be addressed through template changes. Low-income countries' health ministries often can't see actual district health expenditures because budget systems combine data at primary care or hospital levels. The Global Fund has supported health financing tracking in several countries: Burkina Faso, Ethiopia, Democratic Republic of the Congo (DRC), Kenya, Rwanda, Sierra Leone, Senegal, Tanzania, and Zambia; but these efforts are isolated rather than part of a unified strategy to ensure that transition-ready countries have clear expenditure visibility.

What could be improved?

There is room for improvement that we’ve identified as follows:

Develop a concrete post-transition engagement framework.

The Global Fund should proactively outline a menu of non-grant-based support options for countries post-transition. This could include a formal "alumni network" for peer learning, continued access to Global Fund procurement mechanisms for quality assurance, structured technical assistance for specific health system strengthening areas, and global advocacy platforms to share success stories and challenges. This would ensure that the investment in transition pathways culminates in resilient, self-sustaining health systems, not just financial independence.

Operationalize "health sovereignty" and "self-reliance" with clear metrics.

Translate these powerful concepts into actionable, measurable components. This could involve developing a "Health Sovereignty Index" that assesses not just financial independence but also country capacity in governance, data utilization, research and development, local manufacturing, and equitable access. Such an index would provide a holistic view of country ownership and guide targeted support.

Subject co-financing commitments to independent verification.

Mandate that for countries in transition cohorts, co-financing commitment realization be verified by the Office of the Inspector General or accredited external auditors, with findings published prior to allocation decisions. The current self-reporting system has reached its credibility limits. Transparency on verification findings will strengthen the negotiating position of health ministries relative to finance ministries, providing documented evidence of underperformance that can inform advocacy at head-of-state level.

Establish a civil society transition facility.

Dedicate ring-fenced resources to support community and key population organisations in transition settings through multi-year grants for organizational development, government contracting, and diversified fundraising. Eligibility should extend beyond the transition year, acknowledging civil society sustainability aligns with political cycles, not grant cycles. Malaysia and Belize examples show feasibility, but the missing element is systematic application across the portfolio.

Reconcile the cohort model with the Accra Reset's sovereignty claims.

The current document presents transition timelines as a Secretariat determination. If the health sovereignty agenda is to be operationalized meaningfully, countries should propose their own transition pathways within parameters jointly agreed. The Secretariat's role would shift from setting timelines to validating the feasibility of proposed trajectories and the adequacy of accompanying investments. This is not semantic; it addresses the fundamental tension between donor-defined predictability and sovereign-defined ownership.

Conclusion

The GC8 Strategic Shifts document provides a realistic assessment of the Global Fund's environment in the coming decade. The move towards intentional, differentiated transition pathways and a focus on co-financing reflect lessons learned from GC6 and GC7. The Secretariat acknowledges that avoiding transition can lead to disorderly contraction, and emphasizes that self-reliance offers political backing for difficult discussions.

However, the document's silences are telling: the post-transition gap remains undefined, strategies for civil society financing are lacking; data issues are noted but unresolved. The Africa health sovereignty movement is mentioned, but lacks concrete reforms to transfer authority to governments. With 24 months until GC8 allocations, the Secretariat needs to clarify those points before the implementation.